Literature DB >> 20450503

Transurethral resection of prostate: a comparison of standard monopolar versus bipolar saline resection.

Piyush Singhania1, Dave Nandini, Fernandes Sarita, Pathak Hemant, Iyer Hemalata.   

Abstract

INTRODUCTION: Transurethral resection syndrome is an uncommon but potentially life threatening complication. Various irrigating solutions have been used, normal saline being the most physiological. The recent availability of bipolar cautery has permitted the use of normal saline irrigation.
MATERIAL AND METHODS: In a randomized prospective study, we compared the safety and efficacy of bipolar cautery (using 0.9% normal saline irrigation) versus conventional monopolar cautery (using 1.5% glycine irrigation). Pre and postoperative hemoglobin (Hb) and hematocrit values were compared. Hemodynamics and arterial oxygen saturation were monitored throughout the study. Safety end points were changes in serum electrolytes, osmolarity and Hb/PCV (packed cell volume). Efficacy parameters were the International Prostate Symptom Score (IPSS) and Qmax (maximum flow rate in mL/sec) values.
RESULTS: Mean preoperative prostate size on ultrasound was 60 +/- 20cc. Mean resected weight was 17.6 +/- 10.8 g (glycine) and 18.66 +/- 12.1 g (saline). Mean resection time was 56.76 +/- 14.51 min (glycine) and 55.1 +/- 13.3 min (saline). The monopolar glycine group showed a greater decline in serum sodium and osmolarity (4.12 meq/L and 5.14 mosmol/L) compared to the bipolar saline group (1.25 meq/L and 0.43 mosmol/L). However, this was not considered statistically significant. The monopolar glycine group showed a statistically significant decline in Hb and PCV (0.97 gm %, 2.83, p < 0.005) as compared to the bipolar saline group (0.55 gm % and 1.62, p < 0.05). Patient follow- up (1,3,6 and 12 months postoperatively) demonstrated an improvement in IPSS and Qmax in both the groups.
CONCLUSION: We concluded that bipolar transurethral resection of prostate is clinically comparable to monopolar transurethral resection of prostate with an improved safety profile. However, larger number of patients with longer follow up is essential.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20450503     DOI: 10.1590/s1677-55382010000200008

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  11 in total

Review 1.  Bipolar transurethral resection versus monopolar transurethral resection for benign prostatic hypertrophy: a systematic review and meta-analysis.

Authors:  Yin Tang; Jinhong Li; Chuanxiao Pu; YunJin Bai; HaiChao Yuan; Qiang Wei; Ping Han
Journal:  J Endourol       Date:  2014-06-05       Impact factor: 2.942

2.  Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO.it.

Authors:  Sebastiano Spatafora; Antonio Casarico; Andrea Fandella; Caterina Galetti; Rodolfo Hurle; Elisa Mazzini; Ciro Niro; Massimo Perachino; Roberto Sanseverino; Giovanni Luigi Pappagallo
Journal:  Ther Adv Urol       Date:  2012-12

Review 3.  Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies.

Authors:  Daniel Zainfeld; Siamak Daneshmand
Journal:  Curr Urol Rep       Date:  2017-05       Impact factor: 3.092

4.  Frequency of Electrolyte Derangement after Transurethral Resection of Prostate: Need for Postoperative Electrolyte Monitoring.

Authors:  Wajahat Aziz; M Hammad Ather
Journal:  Adv Urol       Date:  2015-05-18

Review 5.  Plasmakinetic resection technology for the treatment of benign prostatic hyperplasia: evidence from a systematic review and meta-analysis.

Authors:  Sheng Li; Joey S W Kwong; Xian-Tao Zeng; Xiao-Lan Ruan; Tong-Zu Liu; Hong Weng; Yi Guo; Chang Xu; Jin-Zhu Yan; Xiang-Yu Meng; Xing-Huan Wang
Journal:  Sci Rep       Date:  2015-07-09       Impact factor: 4.379

6.  Safety and efficacy of transurethral vaporization of the prostate using plasma kinetic energy: Long-term outcome.

Authors:  Mahmoud Talat; Abdrabuh Mostafa Abdrabuh; Mohammed Elhelali; Ibrahim Elsotohi; Sayed Eleweedy
Journal:  Urol Ann       Date:  2019 Apr-Jun

7.  Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction.

Authors:  Cameron Edwin Alexander; Malo Mf Scullion; Muhammad Imran Omar; Yuhong Yuan; Charalampos Mamoulakis; James Mo N'Dow; Changhao Chen; Thomas Bl Lam
Journal:  Cochrane Database Syst Rev       Date:  2019-12-03

8.  Monopolar versus bipolar transurethral resection of prostate for benign prostatic hyperplasia: Operative outcomes and surgeon preferences, a real-world scenario.

Authors:  Vijay Kumar Sarma Madduri; Malay Kumar Bera; Dilip Kumar Pal
Journal:  Urol Ann       Date:  2016 Jul-Sep

9.  Bipolar transurethral enucleation and resection of the prostate versus bipolar resection of the prostate for prostates larger than 60gr: A retrospective study at a single academic tertiary care center.

Authors:  Yong Wei; Ning Xu; Shao-Hao Chen; Xiao-Dong Li; Qing-Shui Zheng; Yun-Zhi Lin; Xue-Yi Xue
Journal:  Int Braz J Urol       Date:  2016 Jul-Aug       Impact factor: 1.541

10.  Bipolar and monopolar transurethral resection of the prostate are equally effective and safe in this high quality randomized controled trial.

Authors:  Cristiano M Gomes; Julyana K M Moromizato; Thulio B V Brandão
Journal:  Int Braz J Urol       Date:  2021 Jan-Feb       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.